Lowenstein Sandler has advised Relmada Therapeutics. Holland & Hart has advised the book-running managers. Relmada Therapeutics, a clinical-stage biotechnology company listed on Nasdaq under the symbol…
Relmada Therapeutics Announces $100 Million Underwritten Offering

























